🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsCompounding & FormulationHas anyone dealt with fda warning letters to compounding pharmacies? Page 4

Has anyone dealt with fda warning letters to compounding pharmacies?

DebRD_ATL Mon, Aug 5, 2024 at 2:36 AM 50 replies 2,916 viewsPage 4 of 10
TinaHashiRN
Member
345
1,567
Sep 2024
Raleigh, NC
Aug 5, 2024 at 8:16 AM#16

Just wanted to say — for anyone reading this Has anyone dealt thread who is feeling discouraged: it gets better. The first few weeks are the hardest. Hang in there. 💪

50 0SarahChen_PharmD, sarah.morrison, NeuroNate and 47 others
Reply Quote Save Share Report
kevin_tulsa
Member
489
2,123
Jun 2024
Tulsa, OK
Aug 5, 2024 at 8:33 AM#17

DebRD_ATL's experience with Has anyone dealt with fda resonates deeply with mine. I went through almost the identical process — starting dose, titration timeline, side effects, everything.

The main difference: I titrated faster. But the overall trajectory has been remarkably similar. Down 68 lbs in 13 months.

One thing I would add that DebRD_ATL did not mention: the relationship with food fundamentally changed.

35 21Dr.RheumBOS, greg_boulder, quinn_sf and 32 others
Reply Quote Save Share Report
cory_ATX
Member
456
2,123
Jul 2024
Austin, TX
Aug 5, 2024 at 8:50 AM#18

Saving this for reference. Quality thread.

46 17mona_PHX, andrew_nyc, Dr.EndoEP and 43 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
Dr.BariatricHTX
Senior Member
1,456
7,234
Feb 2024
Houston, TX
Aug 5, 2024 at 9:07 AM#19

As a healthcare provider, I want to add some clinical context to this discussion on Has anyone dealt with fda warning.

Building on what DebRD_ATL said — the evidence base here is well-established. The key publications to reference are from the STEP program[1].

Key clinical points:

  1. Efficacy is dose-dependent and typically requires 4-5 weeks to reach steady state
  2. Side effect profile is predictable and usually manageable with standard protocols
  3. Monitoring should include baseline labs and follow-up at 3-month intervals
  4. Patient education significantly improves outcomes and adherence

Standard disclaimer: this is educational, not individualized medical advice.

References:
[1] See thread title for relevant study identification.
Last edited: Aug 5, 2024 at 3:07 PM
2 23stefan_berlin, Dr.EM_Chicago
Reply Quote Save Share Report
Dr.Martinez
Medical Advisor
3,891
28,456
Nov 2023
Boston, MA
Online
Aug 5, 2024 at 9:24 AM#20

Subscribing to this thread. Has anyone dealt with fda is exactly what I've been researching. 🙏

31 8adam_van, Dr.SurgeonPGH, rachel_ABQ and 28 others
Reply Quote Save Share Report

Similar Threads

503A vs 503B compounding — regulatory framework explained4 replies
Compounded semaglutide stability: accelerated degradation study results6 replies
Lyophilized vs liquid peptides — stability and bioavailability comparison18 replies
Bacteriostatic water sourcing and sterility considerations8 replies
State-by-state compounding pharmacy regulations — 2026 map8 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register